Physician Waivers to Prescribe Buprenorphine Increase Potential Access to Effective Treatment Options to Address Opioid Overdose Crisis.

Quarterly Insights from the RAND Drug Policy Research Center

Join RAND on Facebook Follow RAND on Twitter

Quarterly insights from the RAND Drug Policy Research Center

FEB 15, 2016

Hand with syringe and lighter under spoon with heroin

Photo by ermingut/iStock

Waivers to Prescribe Buprenorphine Increase Access to Opioid Treatment Options

The increased number and geographic distribution of physicians obtaining waivers to prescribe buprenorphine has widened potential access to effective treatment for those with addiction to heroin or prescription painkillers. Read more »

woman counseling another woman

Photo by Cathy Yeulet/iStock

Brief Treatment for Substance Use Disorders: A Guide for Behavioral Health Providers

This clinician guidebook describes a six-session brief treatment for patients with alcohol and opiate use disorders using a motivational enhancement/cognitive behavioral therapy (MET/CBT) approach. Read more »

man vaping with an electronic cigarette

Photo by Marccophoto/iStock

Medical Marijuana Users More Likely to Consume Edibles and Vaporize

People who use marijuana for medical purposes are much more likely to vaporize or consume edible forms of the drug than recreational users. They are also more likely to report daily or near-daily use and consume more grams per day. Read more »

Man in handcuffs with bottle of alcohol on driver's seat of a car

Photo by Baldur Tryggvason/iStock

Can a Criminal Justice Alcohol Abstention Program with Swift, Certain, and Modest Sanctions Reduce Population Mortality?

Researchers found that implementation of the 24/7 Sobriety Program was associated with a reduction in total deaths at the county level. The associations were most evident among causes of death associated with excessive alcohol use. Read more »

New York City Skyline - Midtown and Empire State Building

Photo by Filippo Bacci/iStock

Join Us in New York City

DPRC is pleased to announce the inaugural Americas Regional Meeting of the International Society for the Study of Drug Policy (ISSDP). The meeting will be held in conjunction with the NYU Marron Institute Cannabis Summit in New York City, April 17-18, 2016. Read more »

Trending Publications

Reviewing and Interpreting the Effects of Brief Alcohol Interventions

U.S. Needs to Improve Community-Based Drug, Alcohol Prevention

How Legalizing Marijuana in Vermont Might Affect Revenues, Budgets

DPRC in the News

Factors in Middle School Tied to Impaired Driving Later On


How 'Mandatory Abstinence' Can Cut Crime and Save Lives

The Washington Post

The Cannabis Experiment: As Marijuana Use Becomes More Acceptable, Researchers Are Scrambling to Answer Key Questions About the Drug.



Beau Kilmer

Beau Kilmer

Codirector, RAND Drug Policy Research Center

Rosalie Liccardo Pacula

Rosalie Liccardo Pacula

Codirector, RAND Drug Policy Research Center

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis.

Follow RAND

Privacy statement

RAND Corporation

RAND Corporation. 1776 Main Street, Santa Monica, CA 90401-3208.
RAND® is a registered trademark.